Imperial College London
Alternate

ProfessorTriciaTan

Faculty of Medicine, Department of Metabolism, Digestion and Reproduction

Chair in Metabolic Medicine and Endocrinology
 
 
 
//

Contact

 

+44 (0)20 3313 8038t.tan

 
 
//

Location

 

6N6ECommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Hope:2018:10.3389/fendo.2018.00442,
author = {Hope, DCD and Tan, TMM and Bloom, SR},
doi = {10.3389/fendo.2018.00442},
journal = {Frontiers in Endocrinology},
title = {No guts, no loss: Toward the ideal treatment for obesity in the twenty-first century},
url = {http://dx.doi.org/10.3389/fendo.2018.00442},
volume = {9},
year = {2018}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Over the last century, our knowledge of the processes which control appetite and weight regulation has developed significantly. The understanding of where gut hormones fit into the control of energy homeostasis in addition to the rapid advancement of pharmacotherapeutics has paved the way for the development of novel gut hormone analogs to target weight loss. Currently, bariatric surgery remains the most efficacious treatment for obesity. The emergence of gut hormone analogs may provide a useful non-surgical addition to the armamentarium in treating obesity. Simply targeting single gut hormone pathways may be insufficiently efficacious, and combination/multiple-agonist approaches may be necessary to obtain the results required for clear clinical impact.
AU  - Hope,DCD
AU  - Tan,TMM
AU  - Bloom,SR
DO  - 10.3389/fendo.2018.00442
PY  - 2018///
SN  - 1664-2392
TI  - No guts, no loss: Toward the ideal treatment for obesity in the twenty-first century
T2  - Frontiers in Endocrinology
UR  - http://dx.doi.org/10.3389/fendo.2018.00442
UR  - http://hdl.handle.net/10044/1/74349
VL  - 9
ER  -
Download